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ABSTRACT
The conserved RNA helicase DDX3 is of major med-
ical importance due to its involvement in numerous
cancers, human hepatitis C virus (HCV) and HIV.
Although DDX3 has been reported to have a wide
variety of cellular functions, its precise role remains
obscure. Here, we raised a new antibody to DDX3
and used it to show that DDX3 is evenly distributed
throughout the cytoplasm at steady state. Consis-
tent with this observation, HA-tagged DDX3 also
localizes to the cytoplasm. RNAi of DDX3 in both
human and Drosophila cells shows that DDX3 is
required for cell viability. Moreover, using RNAi, we
show that DDX3 is required for expression of protein
from reporter constructs. In contrast, we did not
detect a role for DDX3 in nuclear steps in gene
expression. Further insight into the function of
DDX3 came from the observation that its major
interaction partner is the multi-component transla-
tion initiation factor eIF3. We conclude that a pri-
mary function for DDX3 is in protein translation, via
an interaction with eIF3.
INTRODUCTION
Human DDX3 is a ubiquitously expressed  73 kD protein
that belongs to the DEAD box family of ATP-dependent
RNA helicases (1,2). DDX3 (also referred to as DDX3X,
DBX, HLP2, DDX14, DEAD/H (Asp-Glu-Ala-Asp/
His) box polypeptide 3, CAP-Rf, DEAD/H box-3 and heli-
case like protein 2) is located on the X chromosome and is
highly homologous (>90%) to DDX3Y (also called DBY),
which is present on the Y chromosome and expressed only
in the male germ line (1,2). DDX3 has been the subject of
intensive investigation because of its potential medical
importance in both cancer and viral infection as well as
its roles in numerous cellular processes (1–6). DDX3 is
thought to be a key cellular target of Hepatitis C virus
(HCV) core protein (7 9) and is required for HCV RNA
replication (2,10,11). DDX3 also functions as a cellular
cofactor for CRM-dependent nuclear export of HIV
RNA (12). Finally, DDX3 is a component of neuronal
transport granules as well as germinal granules, both of
which are involved in localized mRNP translation
(13 15).
Both DDX3 and its essential yeast homolog, Ded1,
have ATP-dependent RNA helicase activity (12,16,17).
More recently, Ded1 was also shown to be capable of
displacing a protein complex from RNA in the absence
of duplex unwinding (18) and to have RNA chaperone
activity (19). Among the reported roles for Ded1 in
yeast, the most compelling evidence exists for a direct
role in translation initiation. In particular, Ded1 is present
in the cytoplasm and is required for translation in vitro
(20,21) and in vivo (15,20,22). Ded1 also interacts geneti-
cally with several translation initiation factors, including
the well-known DEAD box RNA helicase eIF4A and the
cap-binding protein eIF4E (1,20,23). Additional studies
have led to the model that Ded1 is required, in addition
to eIF4A, for unwinding RNA during scanning for the
translation initiation codon [see refs(24,25) and references
therein].
Signiﬁcantly, several metazoan homologs of Ded1,
including those in Drosophila (known as Belle), mouse
(PL10) and human (DDX3) can rescue the lethal pheno-
type of a ded1 null mutant (8,14,20). Hereafter, for simplic-
ity, we will refer to all of the metazoan homologs as DDX3.
A potential function for metazoan DDX3 in translation
was suggested by the observation that human DDX3
interacts directly with the HCV core protein, and this inter-
action inhibits translation in vitro (8). Moreover, DDX3
was detected in polysomes in Chironomus tetans (26).
However, recent RNAi studies and over-expression of
DDX3 in mammalian cells have led to the view that this
protein does not function in translation initiation, but
instead is a translation repressor (27). In a related observa-
tion, over-expression of yeast Ded1 repressed translation,
*To whom correspondence should be addressed. Tel: +(617) 432-2844; Fax: +(617) 432-3091; Email: rreed@hms.harvard.edu
 2008 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and this protein is present in, and involved in, the forma-
tion of P-bodies (15). Thus, at present, it remains unclear
whether DDX3 functions in translation initiation and/or
translational repression.
The subcellular localization of mammalian DDX3 has
also been diﬃcult to establish. In original immunoﬂuores-
cence (IF) studies in HeLa cells, DDX3 was found concen-
trated in distinct nuclear spots, with only low levels in the
cytoplasm (7). Another study also reported that DDX3
was largely in the nucleus when subcellular fractionation
of the nucleus and cytoplasm was carried out (9). How-
ever, in the same study, ﬂag-tagged DDX3 was found in
the cytoplasm, and the authors suggested that this locali-
zation might be due to the tag (9). In two other studies,
DDX3 was found mostly in the cytoplasm (8,12), but
entered the nucleus when cells were treated with the pro-
tein export inhibitor, leptomycin B, indicating that DDX3
shuttles (12,28,29). Thus, further clariﬁcation of the loca-
lization of DDX3 is important for understanding the func-
tion of this protein.
In this study, we raised a new antibody to DDX3. Using
this antibody or HA-tagged DDX3, we ﬁnd that DDX3 is
predominantly cytoplasmic at steady state. To investigate
the function of this protein, we carried out RNA interfer-
ence of both human and Drosophila DDX3. Signiﬁcantly,
this analysis revealed a dramatic decrease in the levels
of protein generated from reporter constructs with no
apparent defects in nuclear steps in gene expression.
Further insight into the function of DDX3 came from
the observation that DDX3 associates with the cytoplas-
mic multi-subunit translation initiation factor eIF3 in an
RNase insensitive manner. Together, our data indicate
that DDX3 has a conserved general function in promoting
translation, and this function is mediated via an eIF3-
DDX3 interaction.
MATERIALS AND METHODS
Plasmids
The human DDX3X gene, described in Owsianka and
Patel (7), was subcloned into pcDNA3.1 (Invitrogen,
Carlsbad, CA) using Xho I and EcoR V sites. The HA
tag nucleotide sequence was inserted at the 30 end of the
DDX3genebyPCR.TheN-terminal6XHis-taggedDDX3
was constructed by cloning human DDX3X gene into the
protein expression vector pQE30 (Qiagen, Chatsworth,
CA) and expressed in Escherichia coli (QIAexpression,
Qiagen, Chatsworth, CA). The b-globin reporter construct
containing a 30 HA tag was described (30).
Antibodies
A rabbit polyclonal antibody was raised against an
N-terminal peptide [ENALGLDQQFAGLDLNSSDNQS
(Genemed Synthesis, Inc., TX)] of human DDX3X. The
rabbit polyclonal antibody against UAP56 was described
(31). Antibodies to HA tag and eIF3b were from Santa
Cruz Biotechnology, Inc., Santa Cruz, CA. Mouse mono-
clonal antibodies against SAF-B and b-galactosidase were
purchased from Upstate USA, Inc., Charlottesville, VA
and Abcam, Cambridge, MA, respectively.
RNA interference
HeLa cells were plated overnight on 35mm dishes with
glass coverslip bottoms (MatTek Corp., MA) and trans-
fected with lipofectamine 2000 (Invitrogen) and 50nM
siRNA according to the manufacturer’s protocol. The
DDX3-a siRNA target sequence is 50-GAUGCUGGCUC
GUGAUUUCUU-30 (coding region 2025–2045). The
DDX3-b mixture targets 50-GGGAAGGUUUGAUGAU
CGUGG-30 (coding region 1134 1154) and 50-GAAGCC
AGAAAAUUUUCAUAC-30 (coding region 1708 1728).
The siRNA sequences for UAP56/URH49 were described
(32). For Drosophila RNA interference studies, a stable S2
cell line was ﬁrst generated expressing a b-galactosidase
reporter gene (pMT/V5-His-LacZ plasmid, Invitrogen).
The reporter was cotransfected with a hygromycin-resis-
tant selection vector pCoHYGRO (Invitrogen) at a ratio
of 10:1 using calcium phosphate. The stable cell line was
selected in 100 mg/ml hygromycin. For RNAi,  600bp
dsRNAs targeting DDX3, Elp1, Tap or LacZ were trans-
fected into the stable line expressing the reporter using cal-
cium phosphate (33). Two days after transfection, cells
were induced by the addition of 0.5mM CuSO4, and at
18h postinduction, the cell pellets were lysed and used for
western blots, RT–PCR and b-galactosidase activity. For
RT–PCR, total RNA was extracted from S2 cells and
reverse transcription performed with M-MLV reverse tran-
scriptase (Promega, Madison, WI) using 1mg of total RNA
primed with random hexamers. One-tenth of the reaction
was used as template for PCR. b-galactosidase assays were
performed as described (34,35).
HeLacell microinjection, IF and fluorescence in situ
hybridization (FISH)
DNA Microinjection and FISH were performed as
described (30). For microinjection, 50ng/mlo ft h e3H A -
tagged -globin gene was used. For FISH, the 5 end Alexa
Fluor 546 labeled b-globin probe was used (cttcatccacgttca
ccttgccccacagggcagtaacggcagacttctcctcaggagtcaggtgcaccat).
IF was preformed as described (36). DDX3 (1:300),
eIF3b (1:100) and HA (1:100) were used as primary anti-
bodies. The secondary antibodies were rabbit Alexa-488
and mouse Alexa-647 (Invitrogen) diluted to 1:1000 with
IF solution (10% calf serum in PBS). Images were
captured with an EM-CCD camera on an inverted micro-
scope (200M; Zeiss, Thornwood, NY) using Metamorph
software (Molecular Devices, Sunnyvale, CA). For Droso-
phila FISH, an oligo dT probe was used at 10ng/200ml
and the nuclear envelope visualized using FITC-
conjugated wheat germ agglutinin.
LC-MS/MS analysis
LC-MS/MS data was obtained using a LTQ Orbitrap
(Thermoﬁsher, San Jose, CA) mass spectrometer. Dried
peptides were resuspended in 10ml of 5% acetonitrile/
3% acetic acid and 4ml were loaded onto a pulled fused
silica microcapillary column (125mm ID, 12cm bed)
packed with C18 reverse phase resin (Magic C18AQ,
5mm particles; 200A ˚ pore size; Michrom Bioresources,
Auburn, CA). Peptides were resolved using an Agilent
Nucleic Acids Research, 2008, Vol. 36, No. 14 47091100 series binary pump across a 30min linear gradient of
8–25% acetonitrile in 0.2% formic acid at a 250 nl/min
ﬂow rate. In each data collection cycle, one full MS scan
(375–1600m/z) was acquired in the Orbitrap (6 10
4 reso-
lution setting; automatic gain control target of 10
6) fol-
lowed by 10 data-dependent MS/MS scans in the LTQ
(AGC target 5000; threshold 3000) using the 10 most
abundant ions for collision induced dissociation for frag-
mentation. The method dynamically excluded previously
selected ions for 30s, singly charged ions and unassigned
charged states.
RESULTS
To investigate the function of human DDX3, we raised an
antipeptide rabbit polyclonal antibody to a sequence near
the N-terminus (Figure 1A). This antibody detected one
main band by western blot in a HeLa whole cell lysate
(Figure 1B). DDX3 was also speciﬁcally immunoprecipi-
tated from whole cell lysate with the DDX3 antibody but
not by a negative control antibody (a-SAP 130)
(Figure 1C) or other negative control antibodies (data
not shown). We conclude that our DDX3 antibody is
highly speciﬁc for DDX3 and can be used for both western
analysis and immunoprecipitations.
In light of variable reports on the subcellular localiza-
tion of human DDX3, we next used our antibody for IF of
HeLa cells. As shown in Figure 2A, this analysis revealed
that DDX3 was evenly distributed throughout the cyto-
plasm. Moreover, when a ﬁeld of cells was examined by IF
using the DDX3 antibody, the cells all looked similar
suggesting that DDX3 localization does not vary during
the cell cycle (Figure 2B). To further verify the subcellular
localization of DDX3, we expressed HA-tagged DDX3 in
HeLa cells and carried out IF using an HA antibody. As
shown in Figure 2C (lane 1), when a whole cell lysate of
these cells was probed with our DDX3 antibody, HA-
tagged DDX3 was present and expressed at a higher
level than endogenous DDX3. Immunoprecipitation with
an HA-antibody conﬁrmed the identity of HA-DDX3
(Figure 2C, compare lanes 1 and 3). As shown in
Figure 2D, IF using the HA-antibody revealed that HA-
DDX3 is evenly distributed throughout the cytoplasm.
Together, our data indicate that the steady-state localiza-
tion of DDX3 is cytoplasmic.
RNA interference ofhuman DDX3
To assay for eﬀects of DDX3 knockdown on gene expres-
sion, we employed a reporter construct, which contains
the CMV promoter, an HA-tagged b-globin gene (the nat-
ural three exons and two introns) and the BGH polyA
signal (Figure 3A). In previous work, we microinjected
this reporter into the nucleus of HeLa cells and showed
that it underwent eﬃcient transcription, pre-mRNA pro-
cessing and mRNA export (30). In addition, full-length
b-globin protein was synthesized from the reporter
(unpublished and see below). To prepare DDX3 knock-
down cells, an siRNA targeting the coding region from
2025 to 2045 nts was transfected into HeLa cells.
Western analysis showed that DDX3 protein levels were
eﬃciently knocked down by this siRNA but not by nega-
tive control siRNAs or lipofectamine alone (Figure 3B
and data not shown). We then carried out IF of the con-
trol or DDX3 knockdown cells using the DDX3 antibody,
which conﬁrmed speciﬁc knockdown of DDX3
(Figure 3C). To determine whether DDX3 knockdown
aﬀects expression of the HA-tagged b-globin reporter,
we microinjected it into the nucleus of the DDX3 or con-
trol knockdown HeLa cells (Figure 3D G). A nuclear
injection marker (FITC-conjugated dextran) was coin-
jected to identify the cells containing the HA-tagged
b-globin reporter (Figure 3D and E). After microinjection,
the cells were incubated for 2.5h to allow expression of the
reporter, and then the levels of b-globin protein were
determined by IF using an HA-antibody (Figure 3F
and G). Strikingly, this analysis revealed that the levels
of b-globin protein were severely diminished in the
DDX3 knockdown cells (Figure 3G) but not in the control
cells (Figure 3F). The same results were obtained using a
mixture of two siRNAs targeting the coding region from
1134 to 1154 nts and from 1708 to 1728 nts (data not
shown). Together, our data indicate that DDX3 functions
in expression of protein-coding genes. Consistent with an
important role for DDX3 in HeLa cells, our data show
that the two sets of siRNAs targeting DDX3, but not
the negative control, dramatically inhibited cell growth
A   peptide sequence for DDX3 rabbit polyclonal antibody:
     ENALGLDQQFAGLDNSSDNQS
IP from whole
cell lysate
C 
DDX3-
B
DDX3-
αcntl αDDX3
5% of
input
western with αDDX3
western with αDDX3
whole cell
lystate
Figure 1. Characterization of human DDX3 antipeptide antibody. (A)
The N-terminal amino acid sequence of DDX3 used for raising an
antipeptide rabbit polyclonal antibody. (B) Western blot of HeLa
whole cell lysate using the DDX3 antibody. (C) Immunoprecipitation
from whole cell lysate using a-DDX3 or a-cntl (SAP 130) antibody
followed by western analysis with a-DDX3.
4710 Nucleic Acids Research, 2008, Vol. 36, No. 14(Figure 3H). These data indicate that DDX3 has an
important function in human cells.
The dramatic decrease in b-globin protein levels in
DDX3 knockdown cells could be due to inhibition of
nuclear steps of gene expression, such as transcription,
pre-mRNA processing, mRNA export or due to cytoplas-
mic events such as translation. To investigate whether
defects in nuclear steps in gene expression could explain
Low mag αDDX3 IF B
-HA-DDX3
C
DDX3-
western with
αDDX3
αDDX3 IF DAPI Merge A
DAPI αHA IF Merge
D
23 1
α−HA IP from
whole cell
lysate
5% of
input no tfn  HA-DDX3 
HA-DDX3-
Figure 2. DDX3 is even distributed throughout the cytoplasm using IF. (A) DDX3 was detected in the cytoplasm by IF using our a-DDX3 antibody.
(B) DDX3 localization is not cell cycle dependent. IF of HeLa cells using a-DDX3 antibody at lower ( 100) magniﬁcation is shown. (C) Western
analysis of whole cell lysate using a-DDX3 (lane 1). Immunoprecipitation using a-HA antibody from HeLa whole cell lysate (lane 2) or HeLa whole
cell lysates expressing HA-DDX3 (lane 3) followed by western analysis with a-DDX3 antibody. (D) HA-DDX3 localized in the cytoplasm. IF of
HeLa cells expressing HA-DDX3 was carried out using an HA antibody followed by an Alexa 647-conjugated mouse secondary antibody.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4711the dramatic loss of b-globin protein, we next microin-
jected the b-globin reporter (Figure 4A) into DDX3 and
control knockdown HeLa cell nuclei and used FISH to
determine the nucleocytoplasmic distribution of b-globin
mRNA and also to quantitate total mRNA levels. The
protein UAP56, which functions in mRNA export
(32,37), was knocked down as a positive control.
Western analysis indicated that both DDX3 (Figure 4B)
and UAP56 (Figure 4C) were knocked down eﬃciently.
As shown in Figure 4D, when UAP56 was knocked down,
b-globin transcripts accumulated in the nucleus (in nuclear
speckle domains, A.D. and R.R. unpublished obsverva-
tion), indicating a block in mRNA export. In contrast,
knockdown of DDX3 had no apparent eﬀect on mRNA
export, as b-globin mRNA was detected at similar levels in
the cytoplasm in both DDX3 knockdown cells and the
0 2
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cntl RNAi DDX3 RNAi
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-DDX3
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H
cell number X 10 5
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UAP56
microinjected β-globin HA reporter
days after transfection with siRNA
Figure 3. DDX3 RNA interference inhibits cell growth and expression from a b-globin reporter in HeLa cells. (A) Schematic of HA-tagged b-globin
reporter. Boxes indicate exons and lines indicate introns. The CMV promoter and BGH polyA sites are shown. (B, C) Eﬃciency of DDX3
knockdown (using DDX3-a siRNA) in HeLa cells was examined by western analysis (B) and IF (C). Knockdown control (cntl) was lipofectamine
alone. Loading control in panel b is UAP56. (D–G) Knockdown of DDX3 inhibits expression of b-globin reporter. Femtoliter aliquots of plasmid
DNA (50 mg/ml) containing HA-tagged b-globin was microinjected together with a nuclear injection marker (FITC-conjugated 70 KD-dextran) into
the nucleus of siRNA-treated HeLa cells. After incubation at 378C for 2.5h, b-globin protein expression was detected by IF using an HA antibody.
(H) Knockdown of DDX3 inhibits cell growth. Two sets of siRNAs against DDX3 (DDX3-a, DDX3-b) or lipofectamine alone (cntl) were
transfected into HeLa cells. Cell viability was determined using a hemocytometer after staining cells with trypan blue.
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that the potent eﬀect of DDX3 knockdown on b-globin
protein levels (Figure 3) was not due to a defect in mRNA
export. Previous work showed that proper splicing and
polyadenylation are required for mRNA export (38 40).
Thus, our observation that DDX3 knockdown does not
aﬀect mRNA export indicates that RNA processing
defects are not likely to explain the loss of b-globin protein
in the DDX3 knockdown cells. Consistent with this
conclusion, knockdown of DDX3 had no eﬀect on spli-
cing. Speciﬁcally, RT–PCR using primers that anneal to
exons 1 and 2 of the b-globin reporter revealed a band
with the expected size for mature mRNA (248bp) and no
band of a size corresponding to unspliced pre-mRNA
(379bp) (Figure 4G, lane 1). The same results were
obtained with the negative controls (Figure 4G, lanes
2–5). Finally, using ImageJ (41,42) for quantiﬁcation of
the total levels of FISH signal in the b-globin microinjec-
tion assays (Figure 4D F), we found that the FISH sig-
nals were similar in the UAP56, DDX3 and control
knockdown cells (Figure 4H), indicating that transcription
and/or mRNA stability also could not account for the
dramatic decrease in b-globin protein levels in DDX3
knockdown cells. Thus, our data indicate that DDX3
knockdown results in a major decrease in levels of
b-globin protein without corresponding defects in nuclear
processes in gene expression. Together, these data are con-
sistent with the possibility that translation is a major func-
tion of human DDX3. However, as our data on splicing
and other nuclear steps in gene expression are negative, we
cannot rule out the possibility that DDX3 does play some
role(s) in other steps in gene expression steps prior to
translation (see Discussion section).
RNA interference of Drosophila DDX3
To further investigate the function of DDX3 in metazo-
ans, we carried out RNAi of DDX3 (Belle) in Drosophila
S2 cells. To do this, we ﬁrst generated a stable cell line
containing a copper-inducible lacZ reporter gene. RNAi
of this cell line was then carried out using siRNAs against
the LacZ reporter itself, DDX3 (two diﬀerent siRNAs) or
a negative control protein (Elp1). RT–PCR of LacZ
(lane 1), DDX3 (lanes 2 and 3) and Elp1 (lane 4) revealed
that the knockdowns were eﬃcient (Figure 5A). Western
analysis (Figure 5B), conﬁrmed that b-gal (lane 1), DDX3
(lanes 2 and 3) and the negative control Elp1 (lane 4)
proteins were all eﬃciently knocked down. We next exam-
ined cell viability over a 12-day time course after the
knockdowns (Figure 5C). Signiﬁcantly, the two dsRNAs
targeting DDX3, but not those targeting LacZ or Elp1,
dramatically inhibited cell growth. These data indicate
that DDX3 is required for viability in Drosophila cells.
To further investigate the cellular function of
Drosophila DDX3, CuSO4 was added to the culture
medium to induce LacZ reporter expression. After an
18-h induction, western analysis showed that the levels
of b-gal protein were strongly reduced not only in the
LacZ knockdown cells (Figure 5B, lane 1), but also in
the DDX3 knockdown cells (Figure 5B, lanes 2 and 3).
In contrast, the levels of b-gal were unaﬀected in the
negative control (Elp1) knockdown cells (Figure 5B, lane
4). Consistent with this western result, b-gal enzyme activ-
ity was also decreased in the DDX3 knockdown cells but
not in the negative control knockdown cells (Figure 5D).
Together, these data indicate that Drosophila DDX3 func-
tions in expression of protein-coding genes.
As observed for human DDX3 (Figure 4), we observed
no eﬀects of Drosophila DDX3 knockdown on nuclear
steps in gene expression. For example, mRNA export
was not aﬀected by DDX3 knockdown, but was blocked
by knockdown of the mRNA export receptor TAP
(Figure 5E). Likewise, mRNA levels were not aﬀected in
DDX3 knockdown cells relative to control knockdowns,
as determined by quantitating the FISH signals
(Figure 5F). Finally, in DDX3 knockdown cells, only
spliced Elp1 mRNA, and not unspliced pre-mRNA, was
detected by RT–PCR, indicating that splicing does not
explain the major loss of LacZ reporter protein observed
after DDX3 knockdown (Figure 5A; compare lanes 1–3;
note that the PCR primers used for Elp1 can detect both
spliced and unspliced mRNA). These data are consistent
with the conclusion that Drosophila DDX3 has a major
general role in protein translation but not in nuclear steps
in gene expression. We conclude that the function of
DDX3 in promoting translation is conserved from yeast
(1) to higher eukaryotes.
DDX3 interacts with eIF3
To gain additional insight into the function of DDX3, we
next used our DDX3 antibody to carry out immunopre-
cipitations from total RNase-treated HeLa cytoplasmic
extract. When the immunoprecipitate was analyzed on a
Coomassie-stained gel, a speciﬁc and highly reproducible
set of proteins was detected (Figure 6A, lane 2). These
proteins were not detected in the negative control immu-
noprecipitate (a-cntl which is against the protein SAP 130)
(Figure 6A, lane 1) or in any other negative control immu-
noprecipitates (data not shown). To identify the proteins,
individual bands were analyzed by mass spectrometry.
Strikingly, these data showed that DDX3 was immuno-
precipitated together with at least 10 of the 13 subunits of
the translation initiation factor, eIF3 (subunit j, l and
m were not detected). We then carried out a reciprocal
immunoprecipitation using an antibody to eIF3b.
Signiﬁcantly, DDX3, as well as the eIF3 subunits, were
detected in this immunoprecipitate (Figure 6A, lane 3). To
further verify the speciﬁcity of the DDX3-eIF3 interac-
tion, we carried out immunoprecipitations from RNase-
treated cytoplasmic extract followed by western analysis
using a-DDX3, a-eIF3b and two negative control anti-
bodies (cntl1: a-SAP 130, cntl2: a-SAF-B) (Figure 6B).
These data showed that DDX3 was only present in the
a-DDX3 and a-eIF3b immunoprecipitates. Likewise, eIF3
(subunits b and e) was speciﬁcally detected in the a-DDX3
and a-eIF3b immunoprecipitates but not in the negative
controls (Figure 6B). Finally, when HA-DDX3 was
expressed in HeLa cells followed by an immunoprecipita-
tion using an HA antibody, western analysis revealed that
eIF3b was present in the HA-DDX3 immunoprecipitate,
indicating that HA-DDX3 and eIF3 also speciﬁcally
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is the major interaction partner of DDX3 and that these
factors associate with each other via protein–protein inter-
actions. Whether this interaction is direct or is mediated
via another protein remains to be determined.
DISCUSSION
In this study, we have investigated the function of human
DDX3, an RNA helicase that was originally identiﬁed as a
potential cellular target of HCV (7 9) and more recently
as a cofactor for HIV viral RNA export (12). Our studies
show that RNAi of DDX3 in HeLa cells results in a major
decrease in the levels of protein expressed from a b-globin
reporter construct. The same results were obtained after
RNAi of DDX3 (Belle) in Drosophila cells. In contrast, we
detected no apparent defects in nuclear steps in gene
expression in either HeLa or Drosophila cells. Our data
revealed that DDX3 is predominantly cytoplasmic at
steady state. In addition, we observed a striking associa-
tion between DDX3 and the multi-subunit translation
initiation factor eIF3. Together, the subcellular localiza-
tion of DDX3, the DDX3-eIF3 interaction data and the
RNAi data all support the conclusion that DDX3 func-
tions to promote translation, and this function is con-
served from yeast (1) to humans. In a previous study,
DDX3 was reported to be a translational repressor, and
this eﬀect is thought to be mediated by a direct interaction
between DDX3 and eIF4E (27). We did not obtain evi-
dence for a role of DDX3 in translation repression in our
studies. Although the basis for this discrepancy is not
clear, it may be due to reporter diﬀerences or cell type
speciﬁc diﬀerences in DDX3 regulation, as has been
observed in recent studies (4,27). In this regard, we note
that our RNAi studies were carried out in HeLa cells
whereas Shih et al. (27) used HuH7 cells. It is possible
that DDX3 has dual roles in translation initiation and
translation inhibition depending on the mRNA, the cell
type or other cellular conditions. Finally, in the previous
work (27), translation repression was observed after over-
expression of DDX3. However, it may be diﬃcult to inter-
pret results from over-expressed proteins, possibly even
more so with RNA helicase proteins, such as DDX3,
which may have adverse eﬀects in the cell when present
in large amounts. We also did not detect an interaction
between DDX3 and eIF4E in HeLa extracts using coim-
munoprecipitation/western analysis (data not shown). It is
possible that this interaction is much less abundant that
the DDX3-eIF3 interaction, which is readily detected by
Coomassie stain as well as by western.
Although our studies indicate that DDX3 functions to
promote translation, previous work (1,2) indicates that
DDX3 has features that are not typical of well-known
translation initiation factors. In particular, DDX3 is local-
ized in the cytoplasm as expected for a translation factor,
but upon treatment of cells with leptomycin B, this protein
enters the nucleus, indicating that DDX3 is a shuttling
protein (12). Consistent with this observation, Daneholt
and colleagues found that DDX3 associates with Balbiani
Ring mRNPs cotranscriptionally in the nucleus and also
with polysomes in the cytoplasm (26). DDX3 has also
been detected in puriﬁed mammalian spliceosomal com-
plexes assembled in nuclear extracts (43–45). These data
have led to a model in which DDX3 is loaded onto
mRNA in the nucleus and then functions in translation
in the cytoplasm (26). In yeast, both biochemical and
genetic evidence suggest that Ded1 plays a role, not only
in translation, but also in splicing (22,44,46). In our stu-
dies, we were unable to clearly detect a speciﬁc association
of DDX3 with spliceosomes by western analysis (C.-S.L.
and R.R., unpublished observation). Because DDX3 is an
eIF3c
IF3I
eIF3h
eIF3i
12
eIF3j
3
182
116
82
64
49
37
26
A Coomassie stain of IPs,  +RNase
α-cntl α-DDX3 α-eIF3b
-eIF3b 
-eIF3e
182-
116-
82-
64-
49-
37-
DDX3- *
western with
αDDX3
western with
αeIF3b & αeIF3e
-eIF3a-
-eIF3b-
-eIF3d-
-DDX3-
-eIF3e, f-
-eIF3g-
-eIF3k-
αcntl1 αDDX3 αeIF3b αcntl2
B
αcntl1 αDDX3 αeIF3b αcntl2
5% of
input
5% of
input
Wetern blots of IPs,  +RNase
H-
L-
αHA IP
-HA-DDX3
DDX3
-eIF3b
C
transfected with: − HA-DDX3
western with α-eIF3b:  
western with α-DDX3:
Figure 6. DDX3 associates with the translation initiation factor, eIF3,
via protein–protein interactions. (A) Immunoprecipitations were carried
out using antibodies against DDX3, eIF3b or a negative control anti-
body (SAP 130) from HeLa cytoplasmic extract pretreated with RNase
A. (B) Western blots of the indicated immunoprecipitations were ﬁrst
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a-eIF3e. The right panel shows the blot after probing with both
a-eIF3b and a-eIF3e. The band designated by the asterisk in the
right panel is remaining DDX3 signal.
4716 Nucleic Acids Research, 2008, Vol. 36, No. 14RNA helicase, it is possible that this protein associates
weakly or only transiently with spliceosomes and thus is
diﬃcult to detect by western. We were also unable to
detect a role for DDX3 in splicing or other nuclear steps
in gene expression in DDX3 knockdown cells. However,
from these negative data, we cannot rule out the possibil-
ity that DDX3 does play some role in these steps. For
example, it is possible that DDX3 functions in splicing
of only certain mRNAs, such as localized mRNAs.
Indeed, DDX3 is a component of germinal granules and
neuronal transport granules, which function in localized
mRNP translation (13,14). Thus, DDX3 may be loaded
onto these localized mRNAs in the nucleus and then func-
tion in localized translation in the cytoplasm. Precedent
for nuclear loading of proteins that ultimately function in
the cytoplasm is exempliﬁed by the exon junction complex
(EJC), in which a speciﬁc set of proteins is loaded onto
mRNA during splicing and then functions in NMD or
localized translation in the cytoplasm (47–52). In addition,
splicing enhances translation (53,54) and this enhance-
ment is thought to be mediated by the EJC (55–59).
Further studies are needed to determine whether DDX3
not only has a general role in translation but also has a
speciﬁc role for some mRNAs in localized mRNA transla-
tion and/or in coupling splicing to translation.
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